Evidence map›Paper›PMID 39957624›Full record

ReviewCirculation. Cardiovascular quality and outcomes2025

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub.

Emmanuel Lansac, Kevin M Veen, Andria Joseph, Paula Blancarte Jaber, Frieda Sossi, Zofia Das-Gupta, Suleman Aktaa, J Rafael Sádaba, Vinod H Thourani, Gry Dahle and 26 more

Abstract readConsensus StatementReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Circulation. Cardiovascular quality and outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Emmanuel Lansac *Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France (E.L.).
Kevin M Veen *Department of Cardiothoracic Surgery, Erasmus MC, Rotterdam, the Netherlands (K.M.V., J.J.M.T.).
Andria JosephInternational Consortium for Health Outcomes Measurement, London, UK (A.J., P.B.J., F.S., Z.D.-G.).
Paula Blancarte JaberInternational Consortium for Health Outcomes Measurement, London, UK (A.J., P.B.J., F.S., Z.D.-G.).
Frieda SossiInternational Consortium for Health Outcomes Measurement, London, UK (A.J., P.B.J., F.S., Z.D.-G.).
Zofia Das-GuptaInternational Consortium for Health Outcomes Measurement, London, UK (A.J., P.B.J., F.S., Z.D.-G.).
Suleman AktaaDepartment of Cardiology, Leeds Teaching Hospitals NHS Foundation Trust and Leeds Institute of Cardiovascular and Metabolic Medicine, UK (S.A.).
J Rafael SádabaDepartment of Cardiac Surgery, Navarra University Hospital, Pamplona, Spain (J.R.S.).
Vinod H ThouraniDepartment of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, GA (V.H.T.).
Gry DahleDepartment of Cardiothoracic Surgery, Oslo University Hospital, Norway (G.D.).
Wilson Y SzetoDivision of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia (W.Y.S.).
Faisal BakaeenDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic Main Campus, OH (F.B.).
Elena AikawaDepartment of Medicine, Division of Cardiovascular Medicine (E.A.).
Frederick J SchoenDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (F.J.S.).
Evaldas GirdauskasDepartment of Cardiothoracic Surgery, Augsburg University Hospital, Germany (E.G.).
Aubrey AlmeidaMonash Medical Centre, Melbourne, Victoria, Australia (A.A.).
Andreas ZuckermannDepartment of Cardiac Surgery, Medical University of Vienna, Austria (A.Z.).
Bart MeurisDepartment of Cardiovascular Sciences, KU Leuven, Belgium (B.M.).
John StottHeart Valve Voice Canada, Toronto, ON, Canada (J.S.).
Jolanda KluinDepartment of Cardiothoracic Surgery, Erasmus MC, Rotterdam, the Netherlands (J.K.).
Ruchika MeelDepartment of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa (R.M.).
Wil WoanHeart Valve Voice, Manchester, UK (W.W.).
Daniel Colgan
Hani JneidUniversity of Texas Medical Branch, Galveston, TX (H.J.).
Husam BalkhyDepartment of Surgery, Biological Sciences Division, University of Chicago Medicine, IL (H.B.).
Molly SzerlipBaylor Scott & White The Heart Hospital Plano, TX (M. Szerlip).
Ourania PreventzaDivision of Cardiothoracic Surgery, University of Virginia, Charlottesville, VA (O.P.).
Pinak ShahHeart and Vascular Center, Brigham and Women's Hospital, Boston, MA (P.S.).
Vera H RigolinNorthwestern University Feinberg School of Medicine, Chicago, IL (V.H.R.).
Silvana Medica
Philip Holmes
Marta SitgesHospital Clínic Cardiovascular Institute, Barcelona, Spain (M. Sitges).
Philippe PibarotQuebec Heart and Lung Institute, Quebec City, QC, Canada (P.P.).
Erwan DonalCardiology Department, University Hospital of Rennes, France (E.D.).
Rebecca T HahnDepartment of Cardiology, Columbia Structural Heart & Valve Center, Columbia University, New York (R.T.H.).
Johanna J M TakkenbergDepartment of Cardiothoracic Surgery, Erasmus MC, Rotterdam, the Netherlands (K.M.V., J.J.M.T.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of a patient-related (International Consortium for Health Outcomes Measurement) standard set of outcomes and case mix to be measured in patients with HVD.

methodsA multisociety working group was formed that included patient representatives and representatives from scientific cardiology and cardiothoracic surgery societies that publish current guidelines for HVD. The standard set was developed to monitor the patient's journey from diagnosis to treatment with either a surgical or transcatheter procedure. Candidate clinical and patient-reported outcome measures (PROMs) and case mix were identified through benchmark analyses and systematic reviews. Using an online modified Delphi process, the working group voted on final outcomes/case mix and corresponding definition.

resultsPatients with aortic/mitral/tricuspid valve disease or root/ascending aorta >40 mm were included in the standard set. Patients entered the dataset when the diagnosis of HVD was established, allowing outcome measurement in the preprocedural, periprocedural, and postprocedural phases of patients' lives. The working group defined 5 outcome domains: vital status, patient-reported outcomes, progression of disease, cardiac function and durability, and complications of treatment. Subsequently, 16 outcome measures, including 2 patient-reported outcomes, were selected to be tracked in patients with HVD. Case-mix variables included demographic factors, demographic variables, echocardiographic variables, heart catheterization variables, and specific details on aortic/mitral/tricuspid valves and their specific interventions.

conclusionsThrough a unique collaborative effort between patients and cardiology and cardiothoracic surgery societies, a standard set of measures for HVD was developed. This dataset focuses on outcome measurement regardless of treatment, moving from procedure- to patient-centered outcomes. Implementation of this dataset will facilitate global standardization of outcome measurement, allow meaningful comparison between health care systems and evaluation of clinical practice guidelines, and eventually improve patient care for those experiencing HVD worldwide.

Indexed as

Datasets as TopicHeart Valve DiseasesHeart Valve Prosthesis ImplantationHeart ValvesPatient-Centered CarePatient Reported Outcome MeasuresQuality Indicators, Health CareResearch DesignConsensusDelphi TechniqueHumansTreatment OutcomeAHA Scientific Statementsaortic valveheart valve diseasesmitral valveoutcome and process assessment, health carepatient outcome assessmentpatient reported outcome measurestricuspid valve

Identifiers

PMID39957624
PMCPMC11917533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.